SYNAPTIC PHARMACOLOGY OF SINGLE SUBTHALAMIC NEURONS
单个底丘脑神经元的突触药理学
基本信息
- 批准号:6394140
- 负责人:
- 金额:$ 18.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2004-08-31
- 项目状态:已结题
- 来源:
- 关键词:6 hydroxydopamine Parkinson's disease acetylcholine action potentials brain electrical activity calcium flux dihydroxyphenylalanine disease /disorder model dopamine dopamine receptor electrical property experimental brain lesion fluorescent dye /probe glutamate receptor immunocytochemistry laboratory rat neuropharmacology receptor sensitivity substantia nigra subthalamus synapses tissue /cell culture voltage /patch clamp voltage gated channel
项目摘要
DESCRIPTION: (adapted from applicant's abstract) Electrophysiological studies will be conducted in rat brain slices to examine the characteristics of excitatory and inhibitory inputs to subthalamic neurons. Recordings in normal rats will be compared to those of rats treated with 6-hydroxydopamine (6-OHDA) and levodopa-treated animals, which will allow insight into Parkinson's disease. Specific aim 1 is devoted to characterization of voltage-dependent currents and effects of dopamine on membrane properties of subthalamic neurons in vitro. These studies will address the hypothesis that prolonged stimulation of subthalamic neurons reduces their activity because of persistent inactivation of voltage-gated calcium currents or desensitization of glutamate receptors. This hypothesis will specifically address how stimulation of this region "deep brain stimulation "may yield a clinical effect. Specific aim 2 will examine the effects of dopamine, ACh, and other transmitters on synaptic currents in both subthalamic and substantia nigra - reticulata neurons. The choice of dopamine and acetylcholine is logical given that these transmitters are likely to have effects normally. There is a specific hypothesis to be addressed, that is, chronic dopamine depletion and levodopa treatment, akin to Parkinonism, would alter receptor pharmacology. The manner that the experiment will address this hypothesis is not as clear as in specific aim 1. Specific aim 3 will identify ionic mechanisms that are responsible for burst firing in subthalamic neurons. Modulation by dopaminergic manipulations will be examined also. The importance of understanding burst firing is that this type of activity is more likely than single discharge to influence target neurons. Understanding the output of the subthalamic nucleus will clearly have relevance for understanding movement disorders and Parkinsonism. Specific aim 4 is based on previous studies showing that dopamine depletion/levodopa treatment both have chronic effects on GABA and muscarinic receptors in the basal ganglia. Thus it is hypothesized that this treatment will influence the synaptic potentials in both the subthalamic and substantia nigra- reticulata neurons. Therefore, rats which are lesioned with 6-hydroxydopamine or treated with levodopa will be examined in vitro for synaptic changes in the subthalamic nucleus and substantia nigra-reticulata.
描述:(改编自申请者的摘要)电生理学研究将在大鼠脑片上进行,以检查丘脑下丘脑神经元的兴奋性和抑制性输入的特征。正常大鼠的记录将与6-羟基多巴胺(6-OHDA)治疗的大鼠和左旋多巴治疗的动物进行比较,这将使人们能够深入了解帕金森氏症。具体目标1致力于表征电压依赖电流和多巴胺对体外培养的丘脑下丘脑神经元膜特性的影响。这些研究将解决这样一种假设,即对丘脑底核神经元的长期刺激会降低它们的活动,这是因为电压门控钙电流的持续失活或谷氨酸受体的脱敏。这一假说将具体说明刺激这一区域的“脑深部刺激”如何产生临床效果。具体目标2将研究多巴胺、ACh和其他递质对丘脑下部和黑质网状核神经元突触电流的影响。选择多巴胺和乙酰胆碱是合乎逻辑的,因为这些递质可能具有正常的作用。有一个特定的假设需要解决,即慢性多巴胺耗竭和左旋多巴治疗,类似于帕金森症,将改变受体药理学。实验将如何解决这一假说并不像在特定目标1中那样清楚。特定目标3将确定导致丘脑下丘脑神经元爆发放电的离子机制。多巴胺能操纵的调节也将被研究。了解爆发式放电的重要性在于,这种类型的活动比单一放电更有可能影响靶神经元。了解丘脑底核的输出显然与理解运动障碍和帕金森症有关。具体目标4是基于先前的研究表明,多巴胺耗竭/左旋多巴治疗对基底神经节中的GABA和M受体都有慢性影响。因此,推测这种治疗方法会影响丘脑下部和黑质网状核神经元的突触电位。因此,用6-羟基多巴胺损毁或左旋多巴治疗的大鼠,将在体外检查丘脑底核和黑质网状核的突触变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN WILLIAM JOHNSON其他文献
STEVEN WILLIAM JOHNSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN WILLIAM JOHNSON', 18)}}的其他基金
Regulation of VTA dopamine neurons by AMP kinase
AMP 激酶对 VTA 多巴胺神经元的调节
- 批准号:
9567497 - 财政年份:2015
- 资助金额:
$ 18.39万 - 项目类别:
Regulation of VTA dopamine neurons by AMP kinase
AMP 激酶对 VTA 多巴胺神经元的调节
- 批准号:
9339560 - 财政年份:2015
- 资助金额:
$ 18.39万 - 项目类别:
Regulation of VTA dopamine neurons by AMP kinase
AMP 激酶对 VTA 多巴胺神经元的调节
- 批准号:
9007876 - 财政年份:2015
- 资助金额:
$ 18.39万 - 项目类别:
Regulation of VTA dopamine neurons by AMP kinase
AMP 激酶对 VTA 多巴胺神经元的调节
- 批准号:
8752624 - 财政年份:2014
- 资助金额:
$ 18.39万 - 项目类别:
Regulation of VTA dopamine neurons by AMP kinase
AMP 激酶对 VTA 多巴胺神经元的调节
- 批准号:
9068906 - 财政年份:2014
- 资助金额:
$ 18.39万 - 项目类别:
Regulation of VTA dopamine neurons by AMP kinase
AMP 激酶对 VTA 多巴胺神经元的调节
- 批准号:
9279101 - 财政年份:2014
- 资助金额:
$ 18.39万 - 项目类别:
Synaptic regulation of single substantia nigra pars reticulata neurons
单个黑质网状部神经元的突触调节
- 批准号:
8286797 - 财政年份:2008
- 资助金额:
$ 18.39万 - 项目类别:
Synaptic regulation of single substantia nigra pars reticulata neurons
单个黑质网状部神经元的突触调节
- 批准号:
7525652 - 财政年份:2008
- 资助金额:
$ 18.39万 - 项目类别:
Synaptic regulation of single substantia nigra pars reticulata neurons
单个黑质网状部神经元的突触调节
- 批准号:
7624257 - 财政年份:2008
- 资助金额:
$ 18.39万 - 项目类别:
Synaptic regulation of single substantia nigra pars reticulata neurons
单个黑质网状部神经元的突触调节
- 批准号:
7880626 - 财政年份:2008
- 资助金额:
$ 18.39万 - 项目类别:
相似海外基金
Development and Translation Mass Spectrometry Methods to Determine BioMarkers for Parkinson's Disease and Comorbidities
确定帕金森病和合并症生物标志物的质谱方法的开发和转化
- 批准号:
2907463 - 财政年份:2024
- 资助金额:
$ 18.39万 - 项目类别:
Studentship
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 18.39万 - 项目类别:
Research Grant
Promoting Parkinson's disease trial participation in rural and coastal communities
促进农村和沿海社区参与帕金森病试验
- 批准号:
2898794 - 财政年份:2024
- 资助金额:
$ 18.39万 - 项目类别:
Studentship
The Diagnostic and Prognostic Utility of Eye Tracking in Parkinson's Disease and Related Disorders
眼动追踪在帕金森病及相关疾病中的诊断和预后效用
- 批准号:
479285 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Operating Grants
Neurophysiological mechanism underlying freezing of gait in Parkinson's disease: transcutaneous spinal cord stimulation for gait disturbance
帕金森病步态冻结的神经生理机制:经皮脊髓刺激治疗步态障碍
- 批准号:
23K10409 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inhibition of cell-to-cell propagation of alpha-synuclein aggregation by glial cells and its involvement in neuropathology in Parkinson's disease.
神经胶质细胞抑制α-突触核蛋白聚集的细胞间传播及其参与帕金森病的神经病理学。
- 批准号:
23K06928 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Propagation of a-synuclein in Parkinson's disease progress
α-突触核蛋白在帕金森病进展中的传播
- 批准号:
22KJ2095 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Drug-microbiome-host interactions in Parkinson's disease
帕金森病的药物-微生物组-宿主相互作用
- 批准号:
2881438 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Studentship
Ordering the disordered in Parkinson's disease to derive peptide inhibitors of alpha-synuclein toxicity
命令帕金森病患者衍生出α-突触核蛋白毒性的肽抑制剂
- 批准号:
2884235 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Studentship
MICA: How does the pedunculopone nucleus influence treatment responses in Parkinson's disease, and can it be targeted for new treatment strategies
MICA:脚核如何影响帕金森病的治疗反应,是否可以作为新治疗策略的目标
- 批准号:
MR/X005267/1 - 财政年份:2023
- 资助金额:
$ 18.39万 - 项目类别:
Research Grant